XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -280.80%-125.14M | -157.40%-25.1M | -37.00%-2.24M | 107.71%605K | -46.65%-98.4M | -671.83%-32.86M | 71.07%43.73M | -104.02%-1.64M | -161.08%-7.85M | 8.59%-67.1M |
Net income from continuing operations | -712.87%-432.31M | -1,438.09%-37.19M | -122.88%-8.21M | -177.84%-47.82M | -1,035.25%-339.09M | -284.36%-53.18M | -178.69%-2.42M | -120.97%-3.68M | -783.29%-17.21M | -625.40%-29.87M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---3.09M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 5.37%6.49M | 53.58%1.78M | 26.52%1.83M | -10.81%1.56M | -26.76%1.33M | -28.12%6.16M | -41.46%1.16M | -29.04%1.44M | -22.41%1.75M | -21.42%1.81M |
Deferred tax | 1,758.77%296.77M | -83.56%12K | 102.59%49K | 98.94%-65K | 3,091.38%296.78M | -760.18%-17.89M | 102.12%73K | -150.43%-1.89M | -1,052.06%-6.15M | -438.49%-9.92M |
Other non cash items | 208.37%1.51M | 645.54%2.42M | -1,450.00%-405K | -10,081.82%-2.24M | 1,003.82%1.73M | -92.74%490K | 60.89%325K | -98.65%30K | -101.34%-22K | -94.15%157K |
Change In working capital | -339.66%-30.01M | -92.89%2.68M | 61.93%-2.88M | 1,327.69%38.11M | -71.54%-67.92M | 91.48%-6.83M | 165.54%37.65M | -229.86%-7.55M | 181.50%2.67M | 59.12%-39.59M |
-Change in receivables | ---- | ---- | -85.38%-46.69M | 31.13%-17.49M | 12.44%22.43M | -138.27%-14.48M | 100.97%16.15M | -809.86%-25.19M | -47.13%-25.39M | -54.15%19.95M |
-Change in inventory | ---- | ---- | -197.57%-57.93M | 74.90%33.92M | 9.71%-24.99M | 151.24%20.87M | 85.09%48.61M | 28.92%-19.47M | 393.37%19.4M | 16.11%-27.67M |
-Change in prepaid assets | ---- | ---- | 15.80%-3.21M | 391.28%845K | 29.81%-2.28M | -196.55%-7.65M | -122.71%-754K | 49.77%-3.82M | 106.31%172K | -121.78%-3.25M |
-Change in payables and accrued expense | ---- | ---- | 143.91%104.31M | 116.21%22.86M | -125.73%-62.36M | 95.65%-4.23M | 0.13%-29.94M | 23.66%42.77M | -50.89%10.57M | 77.58%-27.63M |
-Change in other working capital | ---- | ---- | 134.85%645K | 2.16%-2.04M | 27.43%-717K | -111.19%-1.34M | -45.20%3.58M | -169.33%-1.85M | -216.14%-2.08M | -202.38%-988K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -280.80%-125.14M | -157.40%-25.1M | -37.00%-2.24M | 107.71%605K | -46.65%-98.4M | -671.83%-32.86M | 71.07%43.73M | -104.02%-1.64M | -161.08%-7.85M | 8.59%-67.1M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -93.72%7.65M | -102.88%-416K | -104.42%-1.94M | -101.28%-716K | 38.69%10.73M | 1,553.29%121.9M | 230.33%14.47M | 412.62%43.98M | 127.37%55.73M | 200.05%7.74M |
Net PPE purchase and sale | -165.72%-4.04M | 22.24%-416K | -7,995.83%-1.94M | -49.79%-716K | -99.59%-964K | 55.90%-1.52M | -121.07%-535K | 98.74%-24K | 38.24%-478K | 7.12%-483K |
Net business purchase and sale | ---12.31M | --0 | --0 | --0 | ---12.31M | ---- | ---- | --0 | --0 | --0 |
Net investment purchase and sale | -80.55%24M | --0 | --0 | --0 | 192.04%24M | 2,597.92%123.42M | 238.16%15M | 461.96%44M | 122.30%56.2M | 213.96%8.22M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -93.72%7.65M | -102.88%-416K | -104.42%-1.94M | -101.28%-716K | 38.69%10.73M | 1,553.29%121.9M | 230.33%14.47M | 412.62%43.98M | 127.37%55.73M | 200.05%7.74M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 98.97%-929K | 99.59%-232K | 100.96%103K | 98.70%-202K | 91.37%-598K | 47.84%-90.38M | -533.87%-57.11M | 7.99%-10.76M | 88.71%-15.58M | 52.48%-6.93M |
Net issuance payments of debt | --0 | --0 | ---- | ---- | ---- | 63.00%-46.25M | ---- | ---- | ---- | ---- |
Net common stock issuance | 105.95%2.15M | --0 | 109.11%770K | 100.01%1K | 151.53%1.38M | -3.63%-36.12M | -26.15%-10M | -7.54%-8.45M | -28.48%-15M | 63.84%-2.68M |
Net other financing activities | 61.55%-3.08M | 73.09%-232K | 71.15%-667K | 65.18%-203K | 53.49%-1.98M | 40.28%-8.01M | 20.41%-862K | 39.78%-2.31M | 55.60%-583K | 40.75%-4.25M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 98.97%-929K | 99.59%-232K | 100.96%103K | 98.70%-202K | 91.37%-598K | 47.84%-90.38M | -533.87%-57.11M | 7.99%-10.76M | 88.71%-15.58M | 52.48%-6.93M |
Net cash flow | ||||||||||
Beginning cash position | -0.46%222.71M | -41.08%130.2M | -29.95%133.04M | -15.31%133.66M | -0.46%222.71M | -44.22%223.74M | 1.76%220.98M | -6.58%189.91M | -48.31%157.83M | -44.22%223.74M |
Current changes in cash | -8,717.35%-118.42M | -2,479.57%-25.75M | -112.93%-4.08M | -100.97%-313K | -33.15%-88.27M | 99.24%-1.34M | -80.16%1.08M | 110.89%31.58M | 132.09%32.29M | 30.74%-66.29M |
Effect of exchange rate changes | -568.35%-1.48M | -354.98%-1.64M | 345.17%1.24M | -51.47%-309K | -301.82%-777K | 121.91%316K | -42.73%642K | 53.57%-507K | 85.60%-204K | 812.96%385K |
End cash Position | -53.84%102.81M | -53.84%102.81M | -41.08%130.2M | -29.95%133.04M | -15.31%133.66M | -0.46%222.71M | -0.46%222.71M | 1.76%220.98M | -6.58%189.91M | -48.31%157.83M |
Free cash flow | -275.71%-129.18M | -159.07%-25.52M | -151.93%-4.19M | 98.67%-111K | -47.03%-99.37M | -1,594.91%-34.38M | 70.59%43.19M | -104.28%-1.66M | -168.95%-8.33M | 8.58%-67.59M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |